Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Epizyme Inc (EPZM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,150,457
  • Shares Outstanding, K 90,730
  • Annual Sales, $ 21,700 K
  • Annual Income, $ -123,630 K
  • 60-Month Beta 3.14
  • Price/Sales 52.77
  • Price/Cash Flow N/A
  • Price/Book 4.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.47
  • Number of Estimates 8
  • High Estimate -0.42
  • Low Estimate -0.53
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +4.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.20 +13.21%
on 03/25/19
13.97 -9.23%
on 04/08/19
+0.41 (+3.34%)
since 03/18/19
3-Month
8.80 +44.09%
on 01/23/19
14.95 -15.18%
on 02/26/19
+3.12 (+32.64%)
since 01/18/19
52-Week
5.14 +146.69%
on 12/24/18
18.70 -32.19%
on 05/24/18
-3.87 (-23.38%)
since 04/18/18

Most Recent Stories

More News
Detailed Research: Economic Perspectives on CarMax, Cameco, American Renal Associates, Donaldson, Epizyme, and Tredegar -- What Drives Growth in Today's Competitive Landscape

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of CarMax, Inc. (NYSE:KMX), Cameco...

ARA : 6.40 (+6.67%)
TG : 18.10 (-0.55%)
KMX : 77.00 (-0.54%)
CCJ : 11.79 (+0.17%)
DCI : 53.55 (+1.04%)
EPZM : 12.68 (+0.48%)
Epizyme Inc Up 76.6% Since SmarTrend Uptrend Call (EPZM)

SmarTrend identified an Uptrend for Epizyme Inc (NASDAQ:EPZM) on January 4th, 2019 at $6.98. In approximately 3 months, Epizyme Inc has returned 76.65% as of today's recent price of $12.33.

EPZM : 12.68 (+0.48%)
Shares of Chemocentryx Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (CCXI , KPTI , EPZM , MYGN , VNDA )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 4.63 (-3.94%)
CCXI : 12.13 (-1.30%)
EPZM : 12.68 (+0.48%)
Uptrend Call Working As Epizyme Inc Stock Rises 74.9% (EPZM)

SmarTrend identified an Uptrend for Epizyme Inc (NASDAQ:EPZM) on January 4th, 2019 at $6.98. In approximately 3 months, Epizyme Inc has returned 74.93% as of today's recent price of $12.21.

EPZM : 12.68 (+0.48%)
Epizyme Announces Closing of Concurrent Public Offerings and Full Exercise of Underwriter's Option to Purchase Additional Shares

Epizyme, Inc. (Nasdaq: EPZM), a late-stage company developing novel epigenetic therapies, today announced the closing of its two concurrent underwritten public offerings of 11,500,000 shares...

EPZM : 12.68 (+0.48%)
72.3% Return Seen to Date on SmarTrend Epizyme Inc Call (EPZM)

SmarTrend identified an Uptrend for Epizyme Inc (NASDAQ:EPZM) on January 4th, 2019 at $6.98. In approximately 2 months, Epizyme Inc has returned 72.35% as of today's recent price of $12.03.

EPZM : 12.68 (+0.48%)
Epizyme Announces Pricing of Concurrent Public Offerings of Common Stock and Series A Preferred Stock

Epizyme, Inc. (Nasdaq:EPZM), a late-stage company developing novel epigenetic therapies, today announced the pricing of two concurrent underwritten public offerings of (i) 10,000,000 shares...

EPZM : 12.68 (+0.48%)
Epizyme Announces Proposed Concurrent Public Offerings of Common Stock and Series A Preferred Stock

Epizyme, Inc. (Nasdaq: EPZM), a late-stage company developing novel epigenetic therapies, today announced that it intends to offer and sell shares of its common stock and Series A convertible...

EPZM : 12.68 (+0.48%)
After Yesterday's Decline of 1.02%, Epizyme Inc Offers Investors Better Value

Epizyme Inc (NASDAQ:EPZM) traded in a range yesterday that spanned from a low of $12.51 to a high of $12.56. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $12.55...

EPZM : 12.68 (+0.48%)
Epizyme Announces Presentations at Upcoming March Investor Conferences

Epizyme, Inc. (NASDAQ:EPZM), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present at the following March investor...

EPZM : 12.68 (+0.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade EPZM with:

Business Summary

Epizyme, Inc. is a biopharmaceutical company. It engages in the discovery, development, planning, and commercialization of therapeutics for cancers. Epizyme, Inc. is headquartered in Cambridge, Massachusetts.

See More

Key Turning Points

2nd Resistance Point 13.29
1st Resistance Point 12.98
Last Price 12.68
1st Support Level 12.32
2nd Support Level 11.97

See More

52-Week High 18.70
Fibonacci 61.8% 13.52
Last Price 12.68
Fibonacci 50% 11.92
Fibonacci 38.2% 10.32
52-Week Low 5.14

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar